A nanochitosan-D-galactose formulation increases the accumulation of primaquine in the liver (2024)
Source: Antimicrobial Agents and Chemotherapy. Unidade: FFCLRP
Subjects: ANTIMALÁRICOS, FARMACOCINÉTICA, QUITOSANA, FÍGADO, NANOPARTÍCULAS
ABNT
GOMES, F. et al. A nanochitosan-D-galactose formulation increases the accumulation of primaquine in the liver. Antimicrobial Agents and Chemotherapy, v. 68, n. 5, p. 1-13, 2024Tradução . . Disponível em: https://doi.org/10.1128/aac.00915-23. Acesso em: 18 nov. 2024.APA
Gomes, F., Ribeiro, A. C., Sanches, G. S., Borges, H. S., Takahashi, L. A. U., Daniel-Ribeiro, C. T., et al. (2024). A nanochitosan-D-galactose formulation increases the accumulation of primaquine in the liver. Antimicrobial Agents and Chemotherapy, 68( 5), 1-13. doi:10.1128/aac.00915-23NLM
Gomes F, Ribeiro AC, Sanches GS, Borges HS, Takahashi LAU, Daniel-Ribeiro CT, Tedesco AC, Nascimento JWL, Carvalho LJM. A nanochitosan-D-galactose formulation increases the accumulation of primaquine in the liver [Internet]. Antimicrobial Agents and Chemotherapy. 2024 ; 68( 5): 1-13.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1128/aac.00915-23Vancouver
Gomes F, Ribeiro AC, Sanches GS, Borges HS, Takahashi LAU, Daniel-Ribeiro CT, Tedesco AC, Nascimento JWL, Carvalho LJM. A nanochitosan-D-galactose formulation increases the accumulation of primaquine in the liver [Internet]. Antimicrobial Agents and Chemotherapy. 2024 ; 68( 5): 1-13.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1128/aac.00915-23